Cellectis (CLLS) Accumulated Expenses (2016 - 2024)

Cellectis (CLLS) has 7 years of Accumulated Expenses data on file, last reported at $8.8 million in Q4 2024.

• In Q4 2024, Accumulated Expenses fell 5.74% year-over-year to $8.8 million; the TTM figure through Dec 2024 stood at $8.8 million (down 5.74% YoY), while the FY2024 annual figure was $8.8 million, down 5.74% from the prior year.
• Accumulated Expenses eased to $8.8 million in Q4 2024, from $9.4 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $9.4 million in Q4 2022 and bottomed at $41526.5 in Q1 2022.
• A 4-year average of $5.6 million and a median of $8.8 million in 2024 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses plunged 79.39% — and 2023, when it retreated 0.56%.
• Year by year, Accumulated Expenses stood at $201441.4 in 2021, then surged by 4576.79% to $9.4 million in 2022, then declined by 0.56% to $9.4 million in 2023, then decreased by 5.74% to $8.8 million in 2024.
• The last three Accumulated Expenses figures came in at $8.8 million (Q4 2024), $9.4 million (Q4 2023), and $9.4 million (Q4 2022), per Business Quant data.

Peer Comparison